Showing results (1-10 of 534) with videos related to
Sort By:
Pageof 54
Expert Review of Clinical Immunology|January 11, 2018
Disease staging and sub setting of interstitial lung disease associated with systemic sclerosis: impact on therapyPeter M George, Athol U WellsExpert Review of Clinical Pharmacology|March 8, 2017
Pirfenidone for the treatment of idiopathic pulmonary fibrosisPeter M George, Athol U WellsThe Lancet. Respiratory Medicine|May 19, 2020
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapyPeter M George, Athol U Wells, R Gisli JenkinsSeminars in Respiratory and Critical Care Medicine|September 4, 2007
Pulmonary function tests in connective tissue diseaseAthol U WellsSeminars in Respiratory and Critical Care Medicine|August 10, 2005
High-resolution computed tomography in the diagnosis of diffuse lung disease: a clinical perspectiveAthol U WellsCurrent Opinion in Pulmonary Medicine|July 7, 2023
Patterns of progression in non-IPF fibrotic interstitial lung diseaseAthol U WellsEuropean Respiratory Review : an Official Journal of the European Respiratory Society|June 4, 2013
Managing diagnostic procedures in idiopathic pulmonary fibrosisAthol U WellsRespiratory Research|June 6, 2013
The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)--practical implicationsAthol U WellsPresse Medicale (Paris, France : 1983)|September 14, 2014
Interstitial lung disease in systemic sclerosisAthol U WellsPageof 54